ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Pathological Outcomes of Eyelid Tumors Running title: Eyelid Tumors

Fatma Savur, Merve Uran, Gülistan Oyur, Fatma Selin Kaya, Havva Kaldırım, Sabiha Güngör Kobat, Hazal İzol Özmen.



Abstract
Download PDF Post

Objectives: To evaluate and compare the pathological outcomes, demographic and clinical features of benign and malignant tumors of the eyelid.
Methods: The records of patients who were operated on for eyelid tumors in the oculoplastic surgery unit of our clinic were retrospectively reviewed. The age and sex of the patient, the location and laterality of the tumor, the histopathological diagnosis of the lesion, and whether it was benign or malignant were recorded.
Results: A total of 251 patients who were operated on for eyelid tumors and underwent histopathological examination were included in the study. Histopathological results showed benign eyelid tumors in 230 patients (91.6%) and malignant eyelid tumors in 21 patients (8.4%). The age of the patients in the malignant eyelid tumors group was significantly higher than in the benign eyelid tumors group (p

Key words: Basal cell carcinoma; intradermal nevus; sebaceous gland carcinoma; squamous cell carcinoma;







Bibliomed Article Statistics

43
35
44
43
11
21
18
11
19
16
30
18
R
E
A
D
S

22

15

32

24

21

48

39

24

42

52

50

26
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.